Viking Therapeutics (VKTX) Reports In-Line Q2 EPS

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), in-line with the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)
• Viking Therapeutics (VKTX) call put ratio 2.4 calls to 1 put with a focus on September 25 weekly calls as share price up 31%